pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-125a |
Genomic Coordinates | chr17: 17830812 - 17830879 |
Description | Mus musculus miR-125a stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-125a-5p |
Sequence | 6| UCCCUGAGACCCUUUAACCUGUGA |29 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Ppp1ca | ||||||||||||||||||||
Synonyms | Ppp1c, dism2 | ||||||||||||||||||||
Description | protein phosphatase 1, catalytic subunit, alpha isoform | ||||||||||||||||||||
Transcript | NM_031868 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Ppp1ca | |||||||||||||||||||||
3'UTR of Ppp1ca (miRNA target sites are highlighted) |
>Ppp1ca|NM_031868|3'UTR 1 CCTCCATGTGCTGCCCTTCTGCCCCAGATCGTTTGTACAGAAATCATGCTGCCATGGGTCACACTGGCCTCTCAGGCCCA 81 CCCGTCACGGGGAACACACAGCGTTAAGTGTCTTTCCTTTATTTTTTAAAGAATCAATAGCAGCATCTAATCTCCCAGGG 161 CTCCCTCCCACCAGCACCTGTGGTGGCTGCAAGTGGAATCCTGGGGCCAAGGCTGCAGCTCAGGGCAATGGCAGACCAGA 241 TTGTGGGTCTCCAGCCTTGCATGGCTGGCAGCCAGATCCTGGGGCAACCCATCTGGTCTCTTGAATAAAGGTCAAAGCTG 321 GATTCTC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | mouse |
Disease | 19045.0 |
Location of target site | 3'UTR |
Original Description (Extracted from the article) |
...
"miR-125a significantly down-regulated the 3芒鈧虏UTR reporters of multiple protein phosphatases
... - Guo S; Bai H; Megyola CM; Halene S; Krause et al., 2012, Proceedings of the National Academy of Sciences of the United States of America. |
Article |
- Guo S; Bai H; Megyola CM; Halene S; Krause et al. - Proceedings of the National Academy of Sciences of the United States of America, 2012
Deregulation of microRNA (miRNA) expression can lead to cancer initiation and progression. However, limited information exists on the function of miRNAs in cancer maintenance. We examined these issues in the case of myeloproliferative diseases and neoplasms (MPN), a collection of hematopoietic neoplasms regarded as preleukemic, thereby representing early neoplastic states. We report here that microRNA-125a (miR-125a)-induced MPN display a complex manner of oncogene dependence. Following a gain-of-function genomics screen, we overexpressed candidate miR-125a in vivo, which led to phenotypes consistent with an atypical MPN characterized by leukocytosis, monocytosis, splenomegaly, and progressive anemia. The diseased MPN state could be recapitulated in a doxycycline-inducible mouse model. Upon doxycycline withdrawal, the primary MPN phenotypes rapidly resolved after the discontinuation of miR-125a overexpression. However, reinduction of miR-125a led to complex phenotypes, with some animals rapidly developing lethal anemia with extensive damages in the spleen. Forced expression of miR-125a resulted in elevated cellular tyrosine phosphorylation and hypersensitivity toward hematopoietic cytokines. Furthermore, we demonstrate that miR-125a targets multiple protein phosphatases. Our data demonstrate that miR-125a-induced MPN is addicted to its sustained overexpression, and highlight the complex nature of oncogenic miRNA dependence in an early neoplastic state.
LinkOut: [PMID: 23012470]
|
CLIP-seq Support 1 for dataset GSM4656408 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | mouse liver / P7 |
Location of target site | NM_031868 | 3UTR | AAGGCUGCAGCUCAGGGCAAUGGCAGACCAGAUUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE153876 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4751756 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | adipose tissue / RNA sequencing of iBAT 1 |
Location of target site | NM_031868 | 3UTR | AAAGAAUCAAUAGCAGCAUCUAAUCUCCCAGGGCUCCCUCCCACCAGCACCUGUGGUGGCUGCAAGUGGAAUCCUGGGGCCAAGGCUGCAGCUCAGGGCAAUGGCAGACCAGAUUGUGGGUCUCCAGCCUUGCAUGGCUGGCAGCCAGAUCCUGGGGCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE142677 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4751757 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | adipose tissue / RNA sequencing of iBAT 2 |
Location of target site | NM_031868 | 3UTR | GGCCAAGGCUGCAGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE142677 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4751758 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | adipose tissue / RNA sequencing of iBAT 3 |
Location of target site | NM_031868 | 3UTR | CCUGGGGCCAAGGCUGCAGCUCAGGGCAAUGGCAGACCAGAUUGUGGGUCUCCAGCCUUGCAUGGCUGGCAGCCAGAUCCUGGGGCAACCCAUCUGGUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE142677 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4751759 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | adipose tissue / RNA sequencing of iBAT 4 |
Location of target site | NM_031868 | 3UTR | AGGGCAAUGGCAGACCAGAUUGUGGGUCUCCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE142677 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4751760 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | adipose tissue / RNA sequencing of eWAT 1 |
Location of target site | NM_031868 | 3UTR | GGGCAAUGGCAGACCAGAUUGUGGGUCUCCAGCCUUGCAUGGCUGGCAGCCAGAUCCUGGGGCAACCCAUCUGGUCUCUUGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE142677 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4751761 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | adipose tissue / RNA sequencing of eWAT 2 |
Location of target site | NM_031868 | 3UTR | GGCUGCAGCUCAGGGCAAUGGCAGACCAGAUUGUGGGUCUCCAGCCUUGCAUGGCUGGCAGCCAGAUCCUGGGGCAACCCAUCUGGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE142677 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM4751762 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | adipose tissue / RNA sequencing of eWAT 3 |
Location of target site | NM_031868 | 3UTR | CUUUCCUUUAUUUUUUAAAGAAUCAAUAGCAGCAUCUAAUCUCCCAGGGCUCCCUCCCACCAGCACCUGUGGUGGCUGCAAGUGGAAUCCUGGGGCCAAGGCUGCAGCUCAGGGCAAUGGCAGACCAGAUUGUGGGUCUCCAGCCUUGCAUGGCUGGCAGCCAGAUCCUGGGGCAACCCAUCUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE142677 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM4751763 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | adipose tissue / RNA sequencing of eWAT 4 |
Location of target site | NM_031868 | 3UTR | GUCUUUCCUUUAUUUUUUAAAGAAUCAAUAGCAGCAUCUAAUCUCCCAGGGCUCCCUCCCACCAGCACCUGUGGUGGCUGCAAGUGGAAUCCUGGGGCCAAGGCUGCAGCUCAGGGCAAUGGCAGACCAGAUUGUGGGUCUCCAGCCUUGCAUGGCUGGCAGCCAGAUCCUGGGGCAACCCAUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE142677 |
CLIP-seq Viewer | Link |
28 mmu-miR-125a-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT001716 | Lin28a | lin-28 homolog A (C. elegans) | 1 | 1 | ||||||||
MIRT005597 | Trim71 | tripartite motif-containing 71 | 4 | 3 | ||||||||
MIRT006310 | Cbx7 | chromobox 7 | 2 | 1 | ||||||||
MIRT006967 | 4632428N05Rik | V-set immunoregulatory receptor | 2 | 1 | ||||||||
MIRT054177 | Ptpn18 | protein tyrosine phosphatase, non-receptor type 18 | 2 | 1 | ||||||||
MIRT054178 | Ptpn7 | protein tyrosine phosphatase, non-receptor type 7 | 2 | 1 | ||||||||
MIRT054179 | Ppp1ca | protein phosphatase 1, catalytic subunit, alpha isoform | 2 | 1 | ||||||||
MIRT054180 | Ppp2ca | protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform | 2 | 1 | ||||||||
MIRT054570 | Traf6 | TNF receptor-associated factor 6 | 3 | 1 | ||||||||
MIRT580227 | Tspan12 | tetraspanin 12 | 2 | 2 | ||||||||
MIRT582368 | Mtf1 | metal response element binding transcription factor 1 | 2 | 2 | ||||||||
MIRT582450 | Mgat4a | mannoside acetylglucosaminyltransferase 4, isoenzyme A | 2 | 2 | ||||||||
MIRT584884 | Antxr2 | anthrax toxin receptor 2 | 2 | 2 | ||||||||
MIRT587193 | Foxk1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT588848 | Snrnp40 | small nuclear ribonucleoprotein 40 (U5) | 2 | 2 | ||||||||
MIRT591275 | Lars2 | leucyl-tRNA synthetase, mitochondrial | 2 | 4 | ||||||||
MIRT592914 | Madd | MAP-kinase activating death domain | 2 | 2 | ||||||||
MIRT594893 | Il1rn | interleukin 1 receptor antagonist | 2 | 4 | ||||||||
MIRT596427 | Hif1an | hypoxia-inducible factor 1, alpha subunit inhibitor | 3 | 3 | ||||||||
MIRT599142 | Dqx1 | DEAQ RNA-dependent ATPase | 2 | 2 | ||||||||
MIRT599717 | Aph1c | aph1 homolog C, gamma secretase subunit | 2 | 2 | ||||||||
MIRT600832 | Gm14137 | predicted gene 14137 | 2 | 2 | ||||||||
MIRT604902 | Jmy | junction-mediating and regulatory protein | 2 | 2 | ||||||||
MIRT605441 | Stat1 | signal transducer and activator of transcription 1 | 2 | 2 | ||||||||
MIRT606092 | Wdr25 | WD repeat domain 25 | 2 | 2 | ||||||||
MIRT732537 | Tnfrsf1b | tumor necrosis factor receptor superfamily, member 1b | 4 | 0 | ||||||||
MIRT734700 | VDR | vitamin D receptor | 2 | 0 | ||||||||
MIRT734824 | Sox11 | SRY (sex determining region Y)-box 11 | 2 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|